Medication info
Janurodi Tablet 25 mg (Sitagliptin hydrochloride hydrate)

Janurodi Tablet 25 mg (Sitagliptin hydrochloride hydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›28.35mg / 1 tablet
Manufacturer / importer
Kwangdong Pharmaceutical Co., Ltd.
Appearance
Pink, round, double-convex, film-coated tablet
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 202004046 · Approved 2020.05.29 · Insurance code 641807050

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer 100 mg once daily as monotherapy or combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When this medicine is administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Assessment of renal function before starting treatment with this medicine and periodically thereafter is recommended, as dosage adjustment is required according to renal function. No dosage adjustment is required in patients with mild renal impairment (eGFR ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is required in patients with moderate renal impairment (eGFR ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). Administer 50 mg once daily to patients with moderate renal impairment (eGFR ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). Administer 25 mg once daily to patients with severe renal impairment (eGFR ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (eGFR < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.

Ingredients

Manufacturer
Kwangdong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

  • Difficulty controlling blood glucose in type 2 diabetes patients
View approved original text

This medication is used to help improve blood glucose control in patients with type 2 diabetes. It is generally administered as an adjunct to a regimen of diet and exercise. For patients who have difficulty controlling their blood glucose, it may be initiated as monotherapy and can be combined with metformin if necessary. Additionally, if blood glucose control is insufficient with monotherapy or combination treatment using sulfonylureas, metformin, thiazolidinediones, or insulin, this medication may be added to improve blood glucose levels. It effectively aids in the improvement of blood glucose control when used in conjunction with various treatment methods.

How to take

Adult dose

Administer 100 mg once daily as monotherapy or combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When this medicine is administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Assessment of renal function before starting treatment with this medicine and periodically thereafter is recommended, as dosage adjustment is required according to renal function. No dosage adjustment is required in patients with mild renal impairment (eGFR ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is required in patients with moderate renal impairment (eGFR ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). Administer 50 mg once daily to patients with moderate renal impairment (eGFR ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). Administer 25 mg once daily to patients with severe renal impairment (eGFR ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (eGFR < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.

Precautions

This medication may rarely cause serious allergic reactions; if you experience symptoms such as skin rash, difficulty breathing, or swelling of the face or neck after taking the medication, you should immediately stop taking it and consult a physician. This medication may cause serious side effects such as pancreatitis, which is inflammation of the pancreas; if you experience abdominal pain, vomiting, or nausea during treatment, you should seek medical attention immediately. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and should be avoided in individuals with known allergies to the drug or its components. Patients with impaired kidney function should have their dosage adjusted and should regularly undergo kidney function checks while taking this medication. The risk of hypoglycemia may increase if this medication is taken with other glucose-lowering agents, especially insulin or sulfonylureas; therefore, careful monitoring of blood glucose levels is advised. If symptoms such as joint pain or skin blistering occur during treatment, you should immediately inform your doctor and discontinue the medication. It is recommended that women who are pregnant or breastfeeding do not take this medication, and its safety and efficacy have not been established in children or adolescents under 18 years of age. Elderly patients may have decreased kidney function; therefore, caution is required when taking this medication, and regular kidney function testing is advisable. In case of overdose, you should seek medical attention immediately, and in some cases, hemodialysis may be necessary. This medication has a low potential for interactions with other drugs, but it is advisable to consult with a physician or pharmacist if certain medications are being taken.

Side effects

Anaphylaxis, angioedema, Stevens-Johnson syndrome, acute pancreatitis, hypoglycemia, upper respiratory infection, nasopharyngitis, headache, diarrhea, abdominal pain, nausea, constipation, vomiting, severe and disability-associated arthralgia, vesicular pemphigoid, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, elevated liver enzymes, acute renal failure, pneumonia, diabetes complications, metabolic acidosis, falls, cardiac arrest, dyspepsia, dizziness, increased serum triglycerides, gastritis, severe hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent air exposure, at a temperature between 1 and 30 degrees Celsius. Storing in this manner helps maintain the efficacy of the medication for a longer period.

Appearance and packaging

Appearance

Pink, round, double-convex, film-coated tablet

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.